Clinical Trial Update: Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated serial lung function in healthy and mild asthmatic adults after oral inhalation of ethanolic solutions containing two concentrations o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Respimat B (RMT-B)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 1 | Status: COMPLETED